TABLE 4.

The association between sickness absence and mortality for employees with chronic conditions excluding participants who died during the first 5 years of follow-up, the GAZEL study.

	Total number of sickness-absence days			Number of sickness-absence episodes >14 days
Sub-population	No. of days per person- year	No. of participants (No. of deaths)	Age-, sex-, and grade- adjusted hazard ratio (95% CI)	No. of episodes per 10 person- years	No. of participants (No. of deaths)	Age-, sex-, and grade- adjusted hazard ratio (95% CI)
Cancer
	0	43 (2)	1.00	0	90 (5)	1.00
	>0–28	92 (4)	1.23 (0.22–6.79)	1–5	51 (4)	1.57 (0.42–5.88)
	>28	54 (11)	5.06 (1.10–23.37)	>5	48 (8)	4.68 (1.01–9.62)
Diabetes
	0	137 (4)	1.00	0	277 (13)	1.00
	>0–28	224 (12)	1.85 (0.58–5.96)	1–5	69 (2)	0.57 (0.13–2.57)
	>28	60 (5)	2.82 (0.70–11.42)	>5	75 (6)	1.61 (0.58–4.48)
Depression
	0	549 (27)	1.00	0	1376 (53)	1.00
	>0–28	1421 (45)	0.71 (0.43–1.15)	1–5	538 (16)	0.85 (0.49–1.50)
	>28	569 (32)	1.30 (0.77–2.21)	>5	625 (35)	1.55 (1.00–2.39)
Chronic bronchitis or asthma
	0	473 (19)	1.00	0	1049 (47)	1.00
	>0–28	878 (43)	1.29 (0.75–2.23)	1–5	275 (16)	1.27 (0.72–2.26)
	>28	222 (21)	2.56 (1.33–4.91)	>5	249 (20)	1.76 (1.02–3.02)
CHD or cerebrovascular disease
	0	165 (13)	1.00	0	335 (20)	1.00
	>0–28	293 (16)	0.65 (0.31–1.36)	1–5	131 (11)	1.53 (0.73–3.23)
	>28	144 (13)	1.08 (0.50–2.35)	>5	136 (11)	1.29 (0.61–2.72)
Hypertension
	0	756 (35)	1.00	0	1540 (66)	1.00
	>0–28	1248 (56)	1.06 (0.69–1.63)	1–5	428 (23)	1.36 (0.84–2.18)
	>28	311 (20)	1.56 (0.88–2.76)	>5	347 (22)	1.62 (0.99–2.65)